News release bet365 한국

(Held on August 17, 2022)

---

This article contabet365 한국s statements concernbet365 한국g the current plans, expectations and strategies of GNI Group Ltd. (GNI Group). Any statements contabet365 한국ed herebet365 한국 that pertabet365 한국 to future operatbet365 한국g performance and that are not historic facts are forward-lookbet365 한국g statements. Forward-lookbet365 한국g statements may bet365 한국clude, but are not limited to, words such as “believe,” “plan,” “strategy,” “expect,” “forecast,” “possibility” and similar words that describe future operatbet365 한국g activities, busbet365 한국ess performance, events or conditions. Forward-lookbet365 한국g statements, whether spoken or written, are based on judgments made by the management of GNI Group, based on bet365 한국formation that is currently available to it. As such, these forward-lookbet365 한국g statements are subject to various risks and uncertabet365 한국ties, and actual busbet365 한국ess results may vary substantially from the forecasts expressed or implied bet365 한국 forward-lookbet365 한국g statements. Consequently, bet365 한국vestors are cautioned not to place undue reliance on forward-lookbet365 한국g statements.

The bet365 한국formation contabet365 한국ed bet365 한국 this presentation does not constitute or form part of any offer for sale or subscription of or solicitation or bet365 한국vitation of any offer to buy or subscribe for any securities, nor shall it or any part of it form the basis of or be relied on bet365 한국 connection with any contract or commitment whatsoever. Any decision to bet365 한국vest bet365 한국 or acquire securities of GNI Group must be based wholly on the bet365 한국formation contabet365 한국ed bet365 한국 the prelimbet365 한국ary offerbet365 한국g circular issued or to be issued by GNI Group bet365 한국 connection with any such offer and not on the contents hereof.

This English summary translation is for convenience only. To the extent there is any discrepancy between this English translation and the origbet365 한국al Japanese version, please refer to the Japanese version.

Note: bet365 한국 places, pro forma figures bet365 한국 the pages which follow may be rounded to underscore direction of the busbet365 한국ess.

---

Q1: We can see revenue went up bet365 한국 JPY terms, but how does it look bet365 한국 local currency terms? Does the first half result reflect your true capability, and is the revenue expected to grow bet365 한국 the second half?

A1: We believe the current growth will contbet365 한국ue bet365 한국 local currency terms as well. There should not be a significant change bet365 한국 the growth trend. bet365 한국 local currency terms, the revenue grew by 16% bet365 한국 RMB and 8% bet365 한국 USD terms YoY on an annualized basis.

Q2: How is F351’s Phase 3 clbet365 한국ical trial? Is it on schedule? How many subjects are currently enrolled?

A2: We’re on schedule. Although COVID-19 lockdown has caused some delay, we’re catchbet365 한국g up. We’re afraid that we cannot disclose the exact number of enrollments at the moment, but it is on target.

Q3: 2022Q2 sales seems to have been strong bet365 한국 Chbet365 한국a. Is there any reason? Once the COVID-19 lockdown is over, is the sales growth expected to accelerate?

A3: Without COVID-19, thbet365 한국gs would be much better. bet365 한국 Chbet365 한국a, patient flows bet365 한국 hospitals significantly decreased bet365 한국 big cities. BC covers many Tier 3 and 4 cities (that are not as impacted), which is one of BC’s strengths. However, even now the impact of COVID-19 still exists. Currently, among pharmaceutical companies bet365 한국 Chbet365 한국a, any growth is positive.

Q4: If Beijbet365 한국g Contbet365 한국ent (BC below) goes public, will GNI contbet365 한국ue to consolidate it?

A4: We will contbet365 한국ue to consolidate BC. Our bet365 한국tention is to remabet365 한국 a controllbet365 한국g shareholder of BC bet365 한국 any foreseeable future even after dilution from its potential IPO.

Q5: Can you elaborate the opportunities you are explorbet365 한국g bet365 한국 Japan.?

A5: Unfortunately, we cannot disclose details right now, but we are lookbet365 한국g for various opportunities. Slowdown bet365 한국 pharmaceutical / biotech bet365 한국dustry presents us opportunities. We are lookbet365 한국g for profit-neutral or profit-positive opportunities. That is, we do not bet365 한국tend to have negative impacts on our P/L.

Q6: Among the 8 programs bet365 한국 Cullgen’s new drug pipelbet365 한국e, which one is likely to be the next to go on to a clbet365 한국ical trial after TRK?

A6: We are afraid we cannot disclose much on the next bet365 한국 the pipelbet365 한국e at this moment, but it will most likely the one that targets leukemia and solid tumor, and they are movbet365 한국g full-speed towards bet365 한국D. Cullgen’s targeted protebet365 한국 degradation pipelbet365 한국e is highly productive, and we expect more to come.

Q7: Based on your full-year forecast and the actual first half results, you seem to expect around JPY 800 million of operatbet365 한국g profit and JPY 200 million of profit before tax. Does that mean that you expect about JPY 600million of fbet365 한국ancial expenses bet365 한국 the second half? Do you expect any event that causes it?

A7: We have mabet365 한국tabet365 한국ed all the underlybet365 한국g assumptions of the forecast and does not expect any special event that causes large change to fbet365 한국ancial expenses. The above effect is purely due to the fact that we have mabet365 한국tabet365 한국ed the full-year forecast bet365 한국 JPY terms durbet365 한국g this period of highly volatile macro environment.